The authors discuss the lessons learnt from the initial trials of single-agent cytokine-based therapies and subsequent efforts to better exploit such agents for the treatment of solid tumors.
[Nature Reviews Clinical Oncology]
Sorry, but the selected Zotpress account can't be found.
